Quantitative evaluation of protein expression as a function of tissue microarray core diameter: Is a large (1.5 mm) core better than a small (0.6 mm) core?

Valsamo Anagnostou, Frank J. Lowery, Konstantinos N. Syrigos, Philip T. Cagle, David L. Rimm

Research output: Contribution to journalArticle

Abstract

Context.-Tissue microarrays (TMAs) have emerged as a high-throughput technology for protein evaluation in large cohorts. This technique allows maximization of tissue resources by analysis of sections from 0.6-mm to 1.5-mm core "biopsies" of standard formalin-fixed, paraffin-embedded tissue blocks and by the processing of hundreds of cases arrayed on a single recipient block in an identical manner. Objective.-To assess the expression of a series of biomarkers as a function of core size. Although pathologists frequently feel better if larger core sizes are used, there is no evidence in the literature showing that large cores are better (or worse) than small cores for assessment of TMAs. Design.-Estrogen receptor, HER2/neu, epidermal growth factor receptor, STAT3, mTOR, and phospho-p70 S6 kinase were measured by immunofluorescence with automated quantitative analysis. One random 0.6-mm field (one 0.6-mm spot) was compared to 6 to 12 fields per spot, representing 1-mm and 1.5-mm cores, for 3 different tumor types. Results.-We show that measurement of a single random 0.6-mm spot was comparable to analysis of the whole 1-mm or 1.5-mm spot (Pearson R coefficient varying from 0.87-0.98) for all markers tested. Conclusions.-Since TMA technology is now being used in all phases of biomarker development, this work shows that TMAs with 0.6-mm cores are as representative as those with any common larger core size for optimization of standardized experimental conditions. Given that a greater number of 0.6-cores can be arrayed in a single master block, use of this core size allows increased throughput and decreased cost.

Original languageEnglish (US)
Pages (from-to)613-619
Number of pages7
JournalArchives of Pathology and Laboratory Medicine
Volume134
Issue number4
StatePublished - Apr 2010
Externally publishedYes

Fingerprint

Proteins
Biomarkers
70-kDa Ribosomal Protein S6 Kinases
Technology
Epidermal Growth Factor Receptor
Estrogen Receptors
Paraffin
Formaldehyde
Fluorescent Antibody Technique
Biopsy
Costs and Cost Analysis
Neoplasms
Pathologists

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Quantitative evaluation of protein expression as a function of tissue microarray core diameter : Is a large (1.5 mm) core better than a small (0.6 mm) core? / Anagnostou, Valsamo; Lowery, Frank J.; Syrigos, Konstantinos N.; Cagle, Philip T.; Rimm, David L.

In: Archives of Pathology and Laboratory Medicine, Vol. 134, No. 4, 04.2010, p. 613-619.

Research output: Contribution to journalArticle

@article{ba8762eed449479b956a2ae485b8c4fd,
title = "Quantitative evaluation of protein expression as a function of tissue microarray core diameter: Is a large (1.5 mm) core better than a small (0.6 mm) core?",
abstract = "Context.-Tissue microarrays (TMAs) have emerged as a high-throughput technology for protein evaluation in large cohorts. This technique allows maximization of tissue resources by analysis of sections from 0.6-mm to 1.5-mm core {"}biopsies{"} of standard formalin-fixed, paraffin-embedded tissue blocks and by the processing of hundreds of cases arrayed on a single recipient block in an identical manner. Objective.-To assess the expression of a series of biomarkers as a function of core size. Although pathologists frequently feel better if larger core sizes are used, there is no evidence in the literature showing that large cores are better (or worse) than small cores for assessment of TMAs. Design.-Estrogen receptor, HER2/neu, epidermal growth factor receptor, STAT3, mTOR, and phospho-p70 S6 kinase were measured by immunofluorescence with automated quantitative analysis. One random 0.6-mm field (one 0.6-mm spot) was compared to 6 to 12 fields per spot, representing 1-mm and 1.5-mm cores, for 3 different tumor types. Results.-We show that measurement of a single random 0.6-mm spot was comparable to analysis of the whole 1-mm or 1.5-mm spot (Pearson R coefficient varying from 0.87-0.98) for all markers tested. Conclusions.-Since TMA technology is now being used in all phases of biomarker development, this work shows that TMAs with 0.6-mm cores are as representative as those with any common larger core size for optimization of standardized experimental conditions. Given that a greater number of 0.6-cores can be arrayed in a single master block, use of this core size allows increased throughput and decreased cost.",
author = "Valsamo Anagnostou and Lowery, {Frank J.} and Syrigos, {Konstantinos N.} and Cagle, {Philip T.} and Rimm, {David L.}",
year = "2010",
month = "4",
language = "English (US)",
volume = "134",
pages = "613--619",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "4",

}

TY - JOUR

T1 - Quantitative evaluation of protein expression as a function of tissue microarray core diameter

T2 - Is a large (1.5 mm) core better than a small (0.6 mm) core?

AU - Anagnostou, Valsamo

AU - Lowery, Frank J.

AU - Syrigos, Konstantinos N.

AU - Cagle, Philip T.

AU - Rimm, David L.

PY - 2010/4

Y1 - 2010/4

N2 - Context.-Tissue microarrays (TMAs) have emerged as a high-throughput technology for protein evaluation in large cohorts. This technique allows maximization of tissue resources by analysis of sections from 0.6-mm to 1.5-mm core "biopsies" of standard formalin-fixed, paraffin-embedded tissue blocks and by the processing of hundreds of cases arrayed on a single recipient block in an identical manner. Objective.-To assess the expression of a series of biomarkers as a function of core size. Although pathologists frequently feel better if larger core sizes are used, there is no evidence in the literature showing that large cores are better (or worse) than small cores for assessment of TMAs. Design.-Estrogen receptor, HER2/neu, epidermal growth factor receptor, STAT3, mTOR, and phospho-p70 S6 kinase were measured by immunofluorescence with automated quantitative analysis. One random 0.6-mm field (one 0.6-mm spot) was compared to 6 to 12 fields per spot, representing 1-mm and 1.5-mm cores, for 3 different tumor types. Results.-We show that measurement of a single random 0.6-mm spot was comparable to analysis of the whole 1-mm or 1.5-mm spot (Pearson R coefficient varying from 0.87-0.98) for all markers tested. Conclusions.-Since TMA technology is now being used in all phases of biomarker development, this work shows that TMAs with 0.6-mm cores are as representative as those with any common larger core size for optimization of standardized experimental conditions. Given that a greater number of 0.6-cores can be arrayed in a single master block, use of this core size allows increased throughput and decreased cost.

AB - Context.-Tissue microarrays (TMAs) have emerged as a high-throughput technology for protein evaluation in large cohorts. This technique allows maximization of tissue resources by analysis of sections from 0.6-mm to 1.5-mm core "biopsies" of standard formalin-fixed, paraffin-embedded tissue blocks and by the processing of hundreds of cases arrayed on a single recipient block in an identical manner. Objective.-To assess the expression of a series of biomarkers as a function of core size. Although pathologists frequently feel better if larger core sizes are used, there is no evidence in the literature showing that large cores are better (or worse) than small cores for assessment of TMAs. Design.-Estrogen receptor, HER2/neu, epidermal growth factor receptor, STAT3, mTOR, and phospho-p70 S6 kinase were measured by immunofluorescence with automated quantitative analysis. One random 0.6-mm field (one 0.6-mm spot) was compared to 6 to 12 fields per spot, representing 1-mm and 1.5-mm cores, for 3 different tumor types. Results.-We show that measurement of a single random 0.6-mm spot was comparable to analysis of the whole 1-mm or 1.5-mm spot (Pearson R coefficient varying from 0.87-0.98) for all markers tested. Conclusions.-Since TMA technology is now being used in all phases of biomarker development, this work shows that TMAs with 0.6-mm cores are as representative as those with any common larger core size for optimization of standardized experimental conditions. Given that a greater number of 0.6-cores can be arrayed in a single master block, use of this core size allows increased throughput and decreased cost.

UR - http://www.scopus.com/inward/record.url?scp=77950531020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950531020&partnerID=8YFLogxK

M3 - Article

C2 - 20367312

AN - SCOPUS:77950531020

VL - 134

SP - 613

EP - 619

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 4

ER -